Clinical trials by condition
Muscular dystrophy clinical trials near you
62 studies for muscular dystrophy are recruiting volunteers at 139 research sites in 29 states.
Also called muscular dystrophies.
- Studies recruiting
- 62
- Research sites
- 139
- States
- 29
What is muscular dystrophy?
Muscular dystrophy (MD) is a group of more than 30 genetic diseases that cause muscle weakness that gets worse over time. The weakness can make it hard to walk and do daily activities, and some types also affect other organs.
The types differ in when they start, which muscles they affect, how severe they are and how fast they get worse. Duchenne is the most common type in children. Becker is milder and gets worse more slowly. Congenital MD is present at birth or starts in the first years of life. Facioscapulohumeral MD often starts in the teen years and first affects the face, shoulders and upper arms.
MD is caused by changes in genes that make proteins needed to strengthen and protect muscles. It can run in families or appear in a family for the first time. It is found with a medical and family history, a physical exam, blood, urine and genetic tests, muscle biopsies, tests of the muscles and nerves, heart tests and imaging. There is no cure; treatment includes physical, occupational, breathing and speech therapy, assistive devices, medicines and surgery.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 17, 2026. Read more on MedlinePlus
Types of muscular dystrophy
Each type has its own page with the studies recruiting for it. The figures on this page include them.
- Duchenne muscular dystrophy (DMD)not enough studies for a page yet
- Facioscapulohumeral muscular dystrophynot enough studies for a page yet
Areas with the most muscular dystrophy studies
Metro areas where studies for muscular dystrophy are recruiting, each study counted once in an area.
By state
Studies for muscular dystrophy recruiting in each state.
- California19 studies · 24 sites
- New York16 studies · 10 sites
- Virginia13 studies · 7 sites
- Massachusetts11 studies · 7 sites
- Texas11 studies · 11 sites
- Arkansas8 studies · 2 sites
- Florida8 studies · 9 sites
- Illinois8 studies · 7 sites
- Iowa7 studies · 5 sites
- Kansas7 studies · 5 sites
All 29 states
Whom the studies accept
The share of the muscular dystrophy studies open to each group. A study can accept several.
- Adults 18 to 6482%
- Adults 65 and over69%
- Children and teens (under 18)71%
- Healthy volunteers13%
- Open to all sexes74%
- Men only26%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Phase 18%
- Phase 1/210%
- Phase 25%
- Phase 2/32%
- Phase 35%
- Phase 43%
- No phase (device, behavioral and other studies)15%
- Not stated53%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Muscular dystrophy clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/muscular-dystrophy, updated November 17, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/muscular-dystrophy">LocalTrial, Muscular dystrophy clinical trials near you</a>, updated November 17, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study muscular dystrophy. A study is counted once however many sites it has.
Updated November 17, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the muscular dystrophy studies near you that may fit. Free and private.
Ready to see what's near you?
Find muscular dystrophy studies near me